These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32102917)

  • 1. Cordycepin Inhibits Cancer Cell Proliferation and Angiogenesis through a DEK Interaction via ERK Signaling in Cholangiocarcinoma.
    Liu T; Zhu G; Yan W; Lv Y; Wang X; Jin G; Cui M; Lin Z; Ren X
    J Pharmacol Exp Ther; 2020 May; 373(2):279-289. PubMed ID: 32102917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cordycepin inhibits cell growth and induces apoptosis in human cholangiocarcinoma.
    Wang C; Mao ZP; Wang L; Zhang FH; Wu GH; Wang DY; Shi JL
    Neoplasma; 2017; 64(6):834-839. PubMed ID: 28895407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFκB pathways in cholangiocarcinoma cells.
    Ke F; Wang Z; Song X; Ma Q; Hu Y; Jiang L; Zhang Y; Liu Y; Zhang Y; Gong W
    Drug Des Devel Ther; 2017; 11():1753-1766. PubMed ID: 28670110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCF21 inhibits tumor-associated angiogenesis and suppresses the growth of cholangiocarcinoma by targeting PI3K/Akt and ERK signaling.
    Duan HX; Li BW; Zhuang X; Wang LT; Cao Q; Tan LH; Qu GF; Xiao S
    Am J Physiol Gastrointest Liver Physiol; 2019 Jun; 316(6):G763-G773. PubMed ID: 30920845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.
    Chen H; Zhu B; Zhao L; Liu Y; Zhao F; Feng J; Jin Y; Sun J; Geng R; Wei Y
    Cell Physiol Biochem; 2018; 47(2):641-653. PubMed ID: 29794468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfated Galactans from Red Seaweed Gracilaria fisheri Target EGFR and Inhibit Cholangiocarcinoma Cell Proliferation.
    Sae-Lao T; Tohtong R; Bates DO; Wongprasert K
    Am J Chin Med; 2017; 45(3):615-633. PubMed ID: 28385079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
    Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
    Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma.
    Seubwai W; Wongkham C; Puapairoj A; Okada S; Wongkham S
    Cancer; 2010 Dec; 116(23):5535-43. PubMed ID: 20681031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growth.
    Hall C; Ehrlich L; Venter J; O'Brien A; White T; Zhou T; Dang T; Meng F; Invernizzi P; Bernuzzi F; Alpini G; Lairmore TC; Glaser S
    Cancer Lett; 2017 Feb; 386():179-188. PubMed ID: 27894959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells.
    Panwong S; Wathikthinnakon M; Kaewkod T; Sawasdee N; Tragoolpua Y; Yenchitsomanus PT; Panya A
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma.
    Chen MH; Yen CC; Cheng CT; Wu RC; Huang SC; Yu CS; Chung YH; Liu CY; Chang PM; Chao Y; Chen MH; Chen YF; Chiang KC; Yeh TS; Chen TC; Huang CY; Yeh CN
    Oncotarget; 2015 Sep; 6(27):23594-608. PubMed ID: 26090720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo.
    Xu D; Ma Y; Zhao B; Li S; Zhang Y; Pan S; Wu Y; Wang J; Wang D; Pan H; Liu L; Jiang H
    Oncol Rep; 2014 May; 31(5):2063-70. PubMed ID: 24603952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: an in vivo and in vitro study.
    Li S; Han Z; Ma Y; Song R; Pei T; Zheng T; Wang J; Xu D; Fang X; Jiang H; Liu L
    Oncol Rep; 2014 Jan; 31(1):145-52. PubMed ID: 24247752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway.
    Zhao W; Yang S; Chen J; Zhao J; Dong J
    Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell.
    Huang M; Huang B; Li G; Zeng S
    BMC Gastroenterol; 2018 Nov; 18(1):169. PubMed ID: 30400838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways.
    Jaidee R; Kukongviriyapan V; Senggunprai L; Prawan A; Jusakul A; Laphanuwat P; Kongpetch S
    Life Sci; 2022 May; 296():120427. PubMed ID: 35218764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actinidia arguta (Hardy Kiwi) Root Extract Exerts Anti-cancer Effects via Mcl-1-Mediated Apoptosis in Cholangiocarcinoma.
    Zhao X; Wen F; Wang W; Lu Z; Guo Q
    Nutr Cancer; 2019; 71(2):246-256. PubMed ID: 30633583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
    Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
    Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cells.
    Yang X; Wang S; Mu Y; Zheng Y
    Oncol Rep; 2016 Oct; 36(4):1799-806. PubMed ID: 27499090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cordycepin reprogramming lipid metabolism to block metastasis and EMT via ERO1A/mTOR/SREBP1 axis in cholangiocarcinoma.
    Zhou X; Li Y; Yang C; Chen D; Wang T; Liu T; Yan W; Su Z; Peng B; Ren X
    Life Sci; 2023 Aug; 327():121698. PubMed ID: 37080351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.